Search Results 91-100 of 21247 for anti-TNF drugs

  1. AMG 181 in Subjects with Moderate to Severe Crohn's Disease - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... A maximum of approximately 80% of subjects with any prior anti-TNF ...

  2. Infliximab (Intravenous Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  3. Infliximab-Qbtx (Intravenous Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  4. Anti-Inflammatory Drugs, Nonsteroidal (Ophthalmic Route) Proper Use - Mayo Clinic

    If certain kinds of infection are present, using this medicine may make the infection worse and possibly lead to eye damage. Dosing. The dose medicines in this ...

  5. Infliximab-Axxq (Intravenous Route) Before Using - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  6. Prescription weight-loss drugs: Can they help you? - Mayo Clinic

    If you answered yes to these questions, a prescription weight-loss drug may be a choice for you. Prescription drugs are medicines that a health care provider ...

  7. Osteoporosis treatment: Medications can help - Mayo Clinic

    Find out more about your options for bone-preserving drugs, including how often you need to take them and what side effects you might expect.

  8. AMG 181 Phase 2 Study in Subjects with Moderate to Severe Ulcerative Colitis - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... Anti-TNF agents; Corticosteroids (non-US sites only). Neurological exam free ...

  9. Anti-fibrotic therapy in the treatment of IPF: Ongoing concerns and current practices - Mayo Clinic

    Pirfenidone and nintedanib are approved for treatment of idiopathic pulmonary fibrosis (IPF), but questions remain regarding indications and timing of ...

  10. Publications - Konstantinos A. Papadakis, M.D. - Mayo Clinic

    Report of the ECCO workshop on anti-TNF therapy failures in inflammatory bowel diseases: biological roles and effects of TNF and TNF antagonists. J Crohns ...